Learn more about our programs
Ovarian

What’s PARP? Getting Up to Speed on New Strategies to Delay Progression of Ovarian Cancer

Now Available On Demand

Watch Now

Thank you to our partner, Sharsheret and the National Ovarian Cancer Coalition
Support for this patient education program was provided by an educational grant from GlaxoSmithKline.

Join expert clinicians and fellow patients for an on-demand educational presentation: “What’s PARP? Getting Up to Speed on New Strategies to Delay Progression of Ovarian Cancer. This presentation will help you find out if you are receiving the most effective treatment for your ovarian cancer. You'll also learn what questions to ask your doctor about preventive options or new therapeutic approaches?

PARP inhibitors offer a new option to delay the progression of ovarian cancer and improve overall quality of life for patients. However, patients need a clear understanding of the benefits of these treatment options, the goals of maintenance therapy, and how PARP inhibition fits into their treatment plan.

Patients like you offer their insights about maintenance therapy and treatment with PARP inhibitors. You will also learn about the side-effects you might experience with PARP inhibitors, to help you recognize and prepare for them. Support sources and advice from from peer and expert medical organizations are also shared.

Watch this program on-demand today!

 

Chapters

  • Chapter 1

    Making sense of maintenance therapy

  • Chapter 2

    Treatment with PARP inhibitors

  • Chapter 3

    Maintaining your quality of life while on maintenance therapy

Speakers

Ursula Matulonis, MD

Chief, Division of Gynecologic Oncology, Dana-Farber Cancer Institute

Courtney Arn, APRN-CNP

Wexner Medical Center, The Ohio State University

Barbara Reeves

Patient Interview Speaker

Patti Smith

Patient Interview Speaker

 

Partners

  • Sharsheret. logo
  • NOCC logo